Glucagon-Like Peptide-1 Receptor Agonists Significantly Cut Retinal Vascular Occlusion Risk in Type 2 Diabetes Patients
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Risk of Retinal Vascular Occlusions.
Abstract
GLP-1 Receptor Agonists significantly reduced the risk of retinal vascular occlusions by 21-34% in type 2 diabetes patients over 1 to 5 years in a large electronic health records study.
